ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Equities
1541
CNE100006624
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.64 HKD | +2.66% | -1.08% | -51.04% |
03/06 | ImmuneOnco Biopharmaceuticals Gets China's Phase 3 Trial Approval for Leukemia Drug | MT |
30/05 | ImmuneOnco Completes Filing with China Regulator for Conversion of H Shares | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-51.04% | 682M | |
+15.64% | 121B | |
+13.50% | 107B | |
-5.38% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.52% | 15.31B | |
+3.11% | 14.08B | |
+25.01% | 11.74B |
- Stock Market
- Equities
- 1541 Stock
- News ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- ImmuneOnco to Present Results of Anti-Cancer Drug Studies at American Convention